These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 12161428)

  • 1. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
    Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
    J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4.
    Chou WC; Prokova V; Shiraishi K; Valcourt U; Moustakas A; Hadzopoulou-Cladaras M; Zannis VI; Kardassis D
    Mol Biol Cell; 2003 Mar; 14(3):1279-94. PubMed ID: 12631740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMAD3 prevents binding of NKX2.1 and FOXA1 to the SpB promoter through its MH1 and MH2 domains.
    Minoo P; Hu L; Zhu N; Borok Z; Bellusci S; Groffen J; Kardassis D; Li C
    Nucleic Acids Res; 2008 Jan; 36(1):179-88. PubMed ID: 18003659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene.
    Costamagna E; García B; Santisteban P
    J Biol Chem; 2004 Jan; 279(5):3439-46. PubMed ID: 14623893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads.
    Sánchez-Elsner T; Ramírez JR; Sanz-Rodriguez F; Varela E; Bernabéu C; Botella LM
    J Mol Biol; 2004 Feb; 336(1):9-24. PubMed ID: 14741200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells.
    Poncelet AC; Schnaper HW
    J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hoxa-9 represses transforming growth factor-beta-induced osteopontin gene transcription.
    Shi X; Bai S; Li L; Cao X
    J Biol Chem; 2001 Jan; 276(1):850-5. PubMed ID: 11042172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
    Nagarajan RP; Liu J; Chen Y
    J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3.
    Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I
    J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
    Feng XH; Lin X; Derynck R
    EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.
    Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D
    J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
    Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.